Acute myeloid leukemia: Clinical Practice Guidelines in Oncology

Margaret R. O'Donnell, Frederick R. Appelbaum, Maria R. Baer, John C. Byrd, Steven E. Coutre, Lloyd E. Damon, Harry P. Erba, Eli Estey, James Foran, Jeffrey Lancet, Lori J Maness-Harris, Peter G. Maslak, Michael Millenson, Joseph O. Moore, Donna Przepiorka, Paul Shami, B. Douglas Smith, Richard M. Stone, Martin S. Tallman

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Approximately 11,960 people will be diagnosed with acute myeloid leukemia (AML) in 2005, and 9,000 patients will die of the disease. As the population ages, the incidence of AML, along with myelodysplasia, appears to be rising. Equally disturbing is the increasing incidence of treatment-related myelodysplasia and leukemia in survivors of tumors of childhood and young adulthood such as Hodgkin's disease, sarcomas, breast and testicular cancers, and lymphomas. Recent large clinical trials have highlighted the need for new, innovative strategies because outcomes for AML patients, particularly older patients, have not substantially changed in the past 3 decades.

Original languageEnglish (US)
Pages (from-to)16-36
Number of pages21
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume4
Issue number1
StatePublished - Jan 1 2006

Fingerprint

Practice Guidelines
Acute Myeloid Leukemia
Incidence
Testicular Neoplasms
Hodgkin Disease
Sarcoma
Survivors
Lymphoma
Leukemia
Clinical Trials
Breast Neoplasms
Population
Neoplasms
Therapeutics

Keywords

  • Acute myeloid leukemia
  • Chemotherapeutic agents
  • Cytogenetics
  • Leukemia treatment
  • NCCN Clinical Practice Guidelines

ASJC Scopus subject areas

  • Oncology

Cite this

O'Donnell, M. R., Appelbaum, F. R., Baer, M. R., Byrd, J. C., Coutre, S. E., Damon, L. E., ... Tallman, M. S. (2006). Acute myeloid leukemia: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network, 4(1), 16-36.

Acute myeloid leukemia : Clinical Practice Guidelines in Oncology. / O'Donnell, Margaret R.; Appelbaum, Frederick R.; Baer, Maria R.; Byrd, John C.; Coutre, Steven E.; Damon, Lloyd E.; Erba, Harry P.; Estey, Eli; Foran, James; Lancet, Jeffrey; Maness-Harris, Lori J; Maslak, Peter G.; Millenson, Michael; Moore, Joseph O.; Przepiorka, Donna; Shami, Paul; Smith, B. Douglas; Stone, Richard M.; Tallman, Martin S.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 4, No. 1, 01.01.2006, p. 16-36.

Research output: Contribution to journalReview article

O'Donnell, MR, Appelbaum, FR, Baer, MR, Byrd, JC, Coutre, SE, Damon, LE, Erba, HP, Estey, E, Foran, J, Lancet, J, Maness-Harris, LJ, Maslak, PG, Millenson, M, Moore, JO, Przepiorka, D, Shami, P, Smith, BD, Stone, RM & Tallman, MS 2006, 'Acute myeloid leukemia: Clinical Practice Guidelines in Oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 1, pp. 16-36.
O'Donnell MR, Appelbaum FR, Baer MR, Byrd JC, Coutre SE, Damon LE et al. Acute myeloid leukemia: Clinical Practice Guidelines in Oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2006 Jan 1;4(1):16-36.
O'Donnell, Margaret R. ; Appelbaum, Frederick R. ; Baer, Maria R. ; Byrd, John C. ; Coutre, Steven E. ; Damon, Lloyd E. ; Erba, Harry P. ; Estey, Eli ; Foran, James ; Lancet, Jeffrey ; Maness-Harris, Lori J ; Maslak, Peter G. ; Millenson, Michael ; Moore, Joseph O. ; Przepiorka, Donna ; Shami, Paul ; Smith, B. Douglas ; Stone, Richard M. ; Tallman, Martin S. / Acute myeloid leukemia : Clinical Practice Guidelines in Oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2006 ; Vol. 4, No. 1. pp. 16-36.
@article{189813bf9adb448381eb8bd210ea0f9a,
title = "Acute myeloid leukemia: Clinical Practice Guidelines in Oncology",
abstract = "Approximately 11,960 people will be diagnosed with acute myeloid leukemia (AML) in 2005, and 9,000 patients will die of the disease. As the population ages, the incidence of AML, along with myelodysplasia, appears to be rising. Equally disturbing is the increasing incidence of treatment-related myelodysplasia and leukemia in survivors of tumors of childhood and young adulthood such as Hodgkin's disease, sarcomas, breast and testicular cancers, and lymphomas. Recent large clinical trials have highlighted the need for new, innovative strategies because outcomes for AML patients, particularly older patients, have not substantially changed in the past 3 decades.",
keywords = "Acute myeloid leukemia, Chemotherapeutic agents, Cytogenetics, Leukemia treatment, NCCN Clinical Practice Guidelines",
author = "O'Donnell, {Margaret R.} and Appelbaum, {Frederick R.} and Baer, {Maria R.} and Byrd, {John C.} and Coutre, {Steven E.} and Damon, {Lloyd E.} and Erba, {Harry P.} and Eli Estey and James Foran and Jeffrey Lancet and Maness-Harris, {Lori J} and Maslak, {Peter G.} and Michael Millenson and Moore, {Joseph O.} and Donna Przepiorka and Paul Shami and Smith, {B. Douglas} and Stone, {Richard M.} and Tallman, {Martin S.}",
year = "2006",
month = "1",
day = "1",
language = "English (US)",
volume = "4",
pages = "16--36",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Acute myeloid leukemia

T2 - Clinical Practice Guidelines in Oncology

AU - O'Donnell, Margaret R.

AU - Appelbaum, Frederick R.

AU - Baer, Maria R.

AU - Byrd, John C.

AU - Coutre, Steven E.

AU - Damon, Lloyd E.

AU - Erba, Harry P.

AU - Estey, Eli

AU - Foran, James

AU - Lancet, Jeffrey

AU - Maness-Harris, Lori J

AU - Maslak, Peter G.

AU - Millenson, Michael

AU - Moore, Joseph O.

AU - Przepiorka, Donna

AU - Shami, Paul

AU - Smith, B. Douglas

AU - Stone, Richard M.

AU - Tallman, Martin S.

PY - 2006/1/1

Y1 - 2006/1/1

N2 - Approximately 11,960 people will be diagnosed with acute myeloid leukemia (AML) in 2005, and 9,000 patients will die of the disease. As the population ages, the incidence of AML, along with myelodysplasia, appears to be rising. Equally disturbing is the increasing incidence of treatment-related myelodysplasia and leukemia in survivors of tumors of childhood and young adulthood such as Hodgkin's disease, sarcomas, breast and testicular cancers, and lymphomas. Recent large clinical trials have highlighted the need for new, innovative strategies because outcomes for AML patients, particularly older patients, have not substantially changed in the past 3 decades.

AB - Approximately 11,960 people will be diagnosed with acute myeloid leukemia (AML) in 2005, and 9,000 patients will die of the disease. As the population ages, the incidence of AML, along with myelodysplasia, appears to be rising. Equally disturbing is the increasing incidence of treatment-related myelodysplasia and leukemia in survivors of tumors of childhood and young adulthood such as Hodgkin's disease, sarcomas, breast and testicular cancers, and lymphomas. Recent large clinical trials have highlighted the need for new, innovative strategies because outcomes for AML patients, particularly older patients, have not substantially changed in the past 3 decades.

KW - Acute myeloid leukemia

KW - Chemotherapeutic agents

KW - Cytogenetics

KW - Leukemia treatment

KW - NCCN Clinical Practice Guidelines

UR - http://www.scopus.com/inward/record.url?scp=33645053537&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645053537&partnerID=8YFLogxK

M3 - Review article

C2 - 16403402

AN - SCOPUS:33645053537

VL - 4

SP - 16

EP - 36

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 1

ER -